Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microbicides 2006 conference.

Gita Ramjee1, Robin Shattock, Sinead Delany

  • 1HIV Prevention Research Unit, Medical Research Council, Durban, South Africa. ramjeeg@mrc.ac.za

AIDS Research and Therapy
|October 14, 2006
PubMed
Summary

New microbicide products offer hope for HIV prevention in Sub-Saharan Africa, where women are disproportionately affected. Research and development are advancing to address this critical public health need.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways.

Microbiology spectrum·2026
Same author

Inhibition of cytomegalovirus reactivation by ex vivo treatment of human kidneys with the SYN002 immunotoxin.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

A Comparison of F/TAF and F/TDF as HIV Pre-Exposure Prophylaxis in a Predominantly Cisgender Women Population in East and South Africa: A Randomized, Factorial, Noninferiority Trial.

Journal of acquired immune deficiency syndromes (1999)·2026
Same author

Pharmacokinetics of Dolutegravir, nucleoside analogues, and intracellular metabolites using plasma separation cards: A comparative analysis with traditional sampling methods in healthy volunteers.

PloS one·2026
Same author

Predictors of virological outcomes after analytical interruption of antiretroviral therapy and HTI vaccination in early treated people with HIV-1._.

Communications medicine·2025
Same author

Africa is an Essential Partner in the Research and Development of an HIV Vaccine.

Current HIV research·2025

Area of Science:

  • Public Health
  • Infectious Diseases
  • Women's Health

Background:

  • Women in Sub-Saharan Africa face a high burden of HIV infections, with limited prevention options.
  • Existing HIV prevention methods like condoms, abstinence, and monogamy are often not feasible for women due to socio-economic and cultural factors.

Purpose of the Study:

  • To provide an update on microbicide research and development.
  • To discuss key issues surrounding microbicides, including ethics, acceptability, access, and community involvement.

Main Methods:

  • The report summarizes discussions from the biannual Microbicides conference held in Cape Town, South Africa.
  • It encompasses updates on basic and clinical science, social and behavioral science, and community mobilization and advocacy.

Related Experiment Videos

Main Results:

  • The conference convened 1,300 scientists, researchers, policymakers, healthcare workers, community members, and advocates.
  • It highlighted the growing global effort to develop and implement microbicide-based HIV prevention strategies.

Conclusions:

  • Microbicides represent a crucial potential tool for HIV prevention, particularly for women in high-prevalence regions.
  • Continued research, ethical considerations, community engagement, and improved access are vital for the success of microbicide implementation.